(Alliance News) - Indivior PLC on Monday said Chief Financial & Operations Officer Mark Crossley will replace Shaun Thaxter as chief executive with immediate effect.
Thaxter, in mutual agreement with the board, is stepping down as chief executive and executive director, the company added.
Indivior shares were trading 0.5% lower at 78.40 pence each on Monday morning in London.
Crossley has been chief financial and operations officer of the drug manufacturer since February 2017. He was chief strategy officer from 2014 to 2017 and also served as finance director where he led the demerger of Indivior from Reckitt Benckiser Group PLC.
Indivior said Ryan Preblick has been appointed interim chief financial officer, adding that it will commence a search for a permanent finance chief and assess whether to hire a separate operations officer. Preblick is currently senior vice president Global Financial Planning & Analysis Commercial Operations, a role he stepped into in January. He joined Indivior in 2012 as regional finance controller for North America, later becoming vice president US Finance.
"Indivior's vision is to ensure patients all around the world have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Mark is a proven leader with a broad strategic and financial skill-set and a deep understanding of the company's guiding principles. The board has full confidence in his ability to drive Indivior forwards and to pursue its vision for the benefit of all stakeholders," said Interim Chair Daniel Tasse.
By Ife Taiwo; ifetaiwo@alliancenews.com.
Copyright 2020 Alliance News Limited. All Rights Reserved.
